Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

PURPOSE: Thymic epithelial tumors are rare malignancies, and there is no standard treatment for patients with advanced disease in whom chemotherapy has failed. Antitumor activity of histone deacetylase (HDAC) inhibitors in this disease has been documented, including one patient with thymoma treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Giaccone, Giuseppe, Rajan, Arun, Berman, Arlene, Kelly, Ronan J., Szabo, Eva, Lopez-Chavez, Ariel, Trepel, Jane, Lee, Min-Jung, Cao, Liang, Espinoza-Delgado, Igor, Spittler, John, Loehrer, Patrick J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107761/
https://ncbi.nlm.nih.gov/pubmed/21502553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.4467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados